CMS Medicare Self-Injectable Guidelines Maintain Split Within Drug Classes
Executive Summary
The Centers for Medicare & Medicaid Services' self-injectables guidelines would still divide Medicare coverage within a therapeutic drug class based on route of administration
You may also be interested in...
Biogen Idec/Elan Tysabri Guaranteed Coverage Under Medicare Part B
Biogen Idec/Elan's once-monthly I.V. formulation of the multiple sclerosis therapy Tysabri guarantees that the product will be covered under Medicare Part B
Biogen Idec/Elan Tysabri Guaranteed Coverage Under Medicare Part B
Biogen Idec/Elan's once-monthly I.V. formulation of the multiple sclerosis therapy Tysabri guarantees that the product will be covered under Medicare Part B
Oral Cancer Drugs, MS Self-Injectables Covered In Medicare Pilot Program
The Medicare conference agreement sets aside $200 mil. to pay for oral cancer therapies under a demonstration project